12 Week,Comparing Safety of HMR1964 & Insulin Aspart Used in Continuous Subcutaneous Infusion in Type 1 Diabetes.
Status:
Completed
Trial end date:
2002-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the safety of HMR 1964 and insulin aspart when used
in external pumps with respect to catheter occlusions, GHb assessment, insulin doses, blood
glucose parameters, hypoglycemic episodes, unexplained hyperglycemia, adverse events,
laboratory data, and vital signs.